Pharmacy
School of Pharmacy
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
The main focus of Dr Burrows’s research team is the identification and characterisation of proteases which potentially represent targets for drug discovery.
One focus is USP17, a deubiquitinase overexpressed in multiple cancers and required for tumour growth and metastases. Dr Burrows has been at the forefront of studies characterising its biological role and assessing its credentials as a therapeutic target.
Another focus is bacterial proteases which contribute to antimicrobial resistance, with the aim of identifying potential antimicrobial targets.
Through his work on proteases, Dr Burrows has also developed an interest in intracellular trafficking, particularly the trafficking of receptors and nanoparticles upon endocytosis.
- Dr James Burrows: School of Pharmacy
Contact info
- View Academic Profile
- j.burrows@qub.ac.uk
- 02890972703
Research Interests
Open to PhD applications in the field of the biology, characterisation and therapeutic targeting of mammalian and microbial proteases. In particular:
Make a PhD enquiry
- USP17 as a therapeutic target in cancer
- Targeting bacterial proteases as an antimicrobial strategy
- Endocytosis and trafficking of nanoparticles
Public outreach & key achievements
Optimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages (2024) Alsa'd, A. A., Greene, M. K., Tayyem, M., Elmore, B., Abed, A., Burden, R. E., Gilmore, B. F., Scott, C. J. & Burrows, J. F. International Journal of Pharmaceutics. 664, 124567.
USP17 is required for peripheral trafficking of lysosomes (2022) Lin, J., McCann, A., Sereesongsaeng, N., Burden, J., Alsa'd, A. A. M., Burden, R., Micu, I., Williams, R., Van Schaeybroeck, S., Evergren, E., Mullan, P., Scott, C. & Burrows, J., EMBO Reports. e51932.
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells (2018) McCann, A. P., Smyth, P., Cogo, F., McDaid, W. J., Jiang, L., Lin, J., Evergren, E., Burden, R. E., Van Schaeybroeck, S., Scott, C. J. & Burrows, J. F. Cell communication and signaling. 16, 77.
Research students
PhD Title | Identifying drug targets to combat Acinetobacter baumannii infections.
Name | Bronagh Elmore
Country | United Kingdom
Years of Study | 2019 - 2025
PhD Title | Identifying Protease Drug Targets to Combat ESKAPE Pathogen Infections
Name | Nezar Faya Al Faya
Country | Saudi Arabia
Years of Study | 2022 - 2025
PhD Title | Design, synthesis and assessment of CDK inhibitors
Name | Mashael Alanazi
Country | Saudi Arabia
Years of Study | 2023 - 2026
Alumni: Where are they now
PhD Title | Therapeutic evaluation of an immunomodulatory nanoparticle in Acute Respiratory Distress Syndrome
Name | Dr Michelle Greene
Years of Study | 2011 - 2015
Country | United Kingdom
Current Position | Senior Postdoctoral Fellow, Future Medicines Institute, Queen’s University Belfast, UK
PhD Title | Manipulating PLGA nanoparticle cellular uptake and trafficking
Name | Dr Alhareth Alsa’d
Years of Study | 2019 - 2022
Country | Jordan
Current Position | Assistant Professor, Biopharmaceutics and Clinical Pharmacy Department, Al-Ahliyya Amman University, Jordan
PhD Title | The role of deubiquitinating enzyme USP17 in Non-Small Cell Lung Cancer as a potential therapeutic target.
Name | Dr Jonathan Burden
Years of Study | 2020 - 2024
Country | United Kingdom
Current Position | Postdoctoral Fellow, Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, UK
Discover More
- Faculty of Medicine, Health & Life Sciences
- School of Pharmacy
- Materials and Advanced Technologies for Healthcare
- Future Medicines Institute